Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 38.85% vs -67.57% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is 12.05% vs -6.60% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 31.18% vs -2.95% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 9.83% vs 21.83% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Krebs Biochem With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -17.05% vs 2.50% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 38.85% vs -67.57% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -117.74% vs -5.98% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 12.05% vs -6.60% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -331.33% vs 196.51% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 31.18% vs -2.95% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 1.06% vs -1.57% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 9.83% vs 21.83% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025